ArticleMedical oncology (Northwood, London, England)2015

Patients with distal intestinal gastric cancer have superior outcome with addition of taxanes to combination chemotherapy, while proximal intestinal and diffuse gastric cancers do not: does biology and location predict chemotherapy benefit?

Ali Murat Sedef et al.PubMed ↗Publisher ↗

No numbers read from the abstract.